Smallpox vaccine gets funding from U.S. gov't for PhIII; Vaccine data to be presented as ASCO;

> Bavarian Nordic has received an extra $32 million from the U.S. government, which will support the Phase III trials of its smallpox vaccine, IMVAMUNE. Press release | Article

> AE37 breast cancer vaccine data will be presented at ASCO 2012. Press release

> Bavarian Nordic plans to present its PROSTVAC data at ASCO, too. Press release

> A newly-discovered protein interaction could be a new target for development of a broad-spectrum HPV vaccine. Press release

> A combination of a cancer vaccine and monoclonal antibodies was effective in a mouse model of glioma. Abstract

And Finally… Cancer vaccine company Tvax Biomedical has withdrawn its planned IPO because of "market conditions." Article

Suggested Articles

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.

AZ is among the companies leading the COVID-19 vaccine race, and after agreeing first to supply the U.K., it's now in talks for delivery worldwide.